Actively Recruiting
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Led by Novartis Pharmaceuticals · Updated on 2026-05-11
350
Participants Needed
1
Research Sites
36 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a United States (US) based, prospective, non-interventional, provider-referral study to evaluate the real-world effectiveness and patient-centered outcomes of remibrutinib in chronic spontaneous urticaria (CSU) patients using validated patient reported outcome (PRO) tools.
CONDITIONS
Official Title
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthcare providers must have an active medical license and be board certified or eligible allergists or dermatologists in the US; nurse practitioners and physician assistants practicing in allergy and dermatology are also eligible
- Healthcare providers must manage CSU patients and agree to participate in the research network or be referred
- Patients must be 18 years or older
- Patients must have a diagnosis of chronic spontaneous urticaria by a healthcare provider
- Patients must have received a prescription for remibrutinib or dupilumab and expect to start treatment
- Patients must have access to an electronic device with internet
- Patients must be able to read and understand English
- Patients must be willing and able to provide consent for participation
You will not qualify if you...
- Patients unable to obtain remibrutinib or dupilumab through samples, commercial means, or assistance programs
- Patients who used oral corticosteroids within 14 days before consent
- Patients who used oral corticosteroids within 14 days before starting remibrutinib or dupilumab
- Patients who previously participated in a remibrutinib or dupilumab clinical trial
- Patients with cognitive impairment that affects their ability to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Novartis
East Hanover, New Jersey, United States, 07936
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here